NCT05021380

Brief Summary

Background: The use of easily accessible biomarkers for assessing young patients' health is important. This study's aim is a measuring stress/immune biomarkers in saliva of healthy school-age children and compare subgroups according to age, sex, stress perception in dental pain related to symptomatic irreversible pulpitis (SIP) and symptomatic apical periodontitis (SAP). Material and methods: 50 children diagnosed with SIP and SAP aged from 6 to 12 years old will be treated with root canal treatment. Dental examination using DMF score and oral hygiene level will be performedby experienced dentists. Salivary samples will be collected three times: before treatment in day of first dental visit (1), after two weeks (2), and after next two weeks = 30 days (3). Additionally, pain and stress perception will be examined by VAS scale and questionnaires dedicated for children anxiety: Frankl behavior rating scale, Venham's anxiety and behavior rating scale. Salivary immunoglobullins A, G, M, opiorphin, free cortisol and amylase will be measured using commercially available ELISA kits. Results will assess which of the measured salivary biomarkers is related to stress and dental pain, suggesting its use for evaluating in non-invasive way in childhood.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2021

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

August 19, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 25, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

August 25, 2021

Status Verified

August 1, 2021

Enrollment Period

8 months

First QC Date

August 19, 2021

Last Update Submit

August 19, 2021

Conditions

Keywords

salivabiomarkerscortisolIgAIgGIgMamylaseopiorphin

Outcome Measures

Primary Outcomes (3)

  • dental pain

    Proportion of subjects showing no increase in dental pain

    30 days

  • salivary biomarkers

    Proportion of subjects showing no increase in salivary biomarkers

    30 days

  • dental anxiety

    Proportion of subjects showing no increase in stress perception

    30 days

Study Arms (1)

Group

50 generally healthy children diagnosed with dental pain as symptomatic irreversible pulpitis (SIP) or symptomatic apical periodontitis (SAP) aged from 6 to 12 years old will be included to the GROUP.

Other: GROUP

Interventions

GROUPOTHER

Non-invasive diagnosis of dental pain, dental root canal treatment, salivary specimen collection from the first visit to next and the last during 4 weeks of dental care

Group

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Subjects will be recruited at University dental clinic in Child and Adolescent Section, one experienced dentist will conduct all dental and salivary collection procedures.

You may qualify if:

  • male or female
  • age 6 - 12 y.o.
  • complaint dental pain
  • diagnosis of symptomatic irreversible pulpitis or symptomatic apical periodontitis
  • assigned agreement to the informed consent form by parents/caregivers and children cooperation

You may not qualify if:

  • use of analgesics or antibiotics prior 48 h before specimen collection
  • having a systemic disease
  • disorders interfering with salivary function or flow
  • regular medication intake interfering with salivary function or flow
  • having temporary infectious disease
  • having neurodevelopmental dysfunction (e.g ADHD)
  • lack of cooperation during dental visits
  • inability to understand the content of the informed consent form by parents/caregivers and children

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Poznan University of Medical Sciences

Poznan, 60-812, Poland

RECRUITING

Related Publications (3)

  • Paszynska E, Roszak M, Slopien A, Boucher Y, Dutkiewicz A, Tyszkiewicz-Nwafor M, Gawriolek M, Otulakowska-Skrzynska J, Rzatowski S, Dmitrzak-Weglarz M. Is there a link between stress and immune biomarkers and salivary opiorphin in patients with a restrictive-type of anorexia nervosa? World J Biol Psychiatry. 2020 Mar;21(3):220-229. doi: 10.1080/15622975.2019.1593502. Epub 2019 Apr 23.

    PMID: 30880537BACKGROUND
  • Boucher Y, Braud A, Dufour E, Agbo-Godeau S, Baaroun V, Descroix V, Guinnepain MT, Ungeheuer MN, Ottone C, Rougeot C. Opiorphin levels in fluids of burning mouth syndrome patients: a case-control study. Clin Oral Investig. 2017 Sep;21(7):2157-2164. doi: 10.1007/s00784-016-1991-0. Epub 2016 Nov 10.

    PMID: 27834029BACKGROUND
  • Slavish DC, Szabo YZ. The effect of acute stress on salivary markers of inflammation: a systematic review protocol. Syst Rev. 2019 May 2;8(1):108. doi: 10.1186/s13643-019-1026-4.

MeSH Terms

Conditions

Stress, PsychologicalToothacheSensation Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorTooth DiseasesStomatognathic DiseasesFacial PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNervous System Diseases

Study Officials

  • Elzbieta Paszynska, Prof

    Poznan University of Medical Sciences, Poland

    PRINCIPAL INVESTIGATOR
  • Yves Boucher, Prof

    Université de Paris & Groupe Hospitalier Pitié Salpêtrière, 75006 Paris, France

    STUDY CHAIR

Central Study Contacts

Elzbieta Paszynska, Prof

CONTACT

Anna Krahel, DDS

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
4 Weeks
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assoc. Prof.

Study Record Dates

First Submitted

August 19, 2021

First Posted

August 25, 2021

Study Start

August 1, 2021

Primary Completion

March 30, 2022

Study Completion

June 30, 2022

Last Updated

August 25, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

we do not plan any individual participant data available share to other researchers

Locations